1. Home
  2. CELU vs HOLO Comparison

CELU vs HOLO Comparison

Compare CELU & HOLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • HOLO
  • Stock Information
  • Founded
  • CELU 2016
  • HOLO 2018
  • Country
  • CELU United States
  • HOLO China
  • Employees
  • CELU N/A
  • HOLO N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • HOLO Computer Software: Programming Data Processing
  • Sector
  • CELU Health Care
  • HOLO Technology
  • Exchange
  • CELU Nasdaq
  • HOLO Nasdaq
  • Market Cap
  • CELU 50.4M
  • HOLO 50.1M
  • IPO Year
  • CELU N/A
  • HOLO N/A
  • Fundamental
  • Price
  • CELU $1.68
  • HOLO $1.57
  • Analyst Decision
  • CELU
  • HOLO
  • Analyst Count
  • CELU 0
  • HOLO 0
  • Target Price
  • CELU N/A
  • HOLO N/A
  • AVG Volume (30 Days)
  • CELU 182.6K
  • HOLO 40.0M
  • Earning Date
  • CELU 12-06-2024
  • HOLO 01-01-0001
  • Dividend Yield
  • CELU N/A
  • HOLO N/A
  • EPS Growth
  • CELU N/A
  • HOLO N/A
  • EPS
  • CELU N/A
  • HOLO N/A
  • Revenue
  • CELU $48,200,000.00
  • HOLO $32,242,196.00
  • Revenue This Year
  • CELU N/A
  • HOLO N/A
  • Revenue Next Year
  • CELU $233.89
  • HOLO N/A
  • P/E Ratio
  • CELU N/A
  • HOLO N/A
  • Revenue Growth
  • CELU 225.94
  • HOLO 326.95
  • 52 Week Low
  • CELU $1.30
  • HOLO $1.06
  • 52 Week High
  • CELU $7.97
  • HOLO $280.00
  • Technical
  • Relative Strength Index (RSI)
  • CELU 37.21
  • HOLO 49.17
  • Support Level
  • CELU $1.85
  • HOLO $1.06
  • Resistance Level
  • CELU $2.18
  • HOLO $1.47
  • Average True Range (ATR)
  • CELU 0.26
  • HOLO 0.15
  • MACD
  • CELU -0.05
  • HOLO 0.03
  • Stochastic Oscillator
  • CELU 5.46
  • HOLO 68.00

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

About HOLO MicroCloud Hologram Inc.

MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library.

Share on Social Networks: